Expression Systems

Co-chair(s):
Charlebois, T., Pfizer, Inc

The focus of this session will be the use of expression systems to significantly accelerate development and eventual commercialization of protein therapeutics. Talks might include discussion of current use (or potential use) of novel expression systems for this purpose, or the use of conventional expression systems in a different manner to achieve acceleration.

Papers: